Vima LLC’s Cocrystal Pharma COCP Stock Holding History

Vima LLC’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-17	Closed	-$18	–	356
2026 Q2	$18	Buy	+17	New	+$21	﹤0.01%	365
2024 Q2	–	Sell	-231	Closed	-$461	–	127
2024 Q1	$461	Buy	231 +6	+3%	+$9	﹤0.01%	389
2023 Q4	$387	Buy	+225	New	+$400	﹤0.01%	377

Other funds holding COCP

Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return

NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Vima LLC's COCP Position: Q3 2026 in Review

Vima LLC sold out of Cocrystal Pharma (COCP) in Q3 2026, closing a stake of 17 shares — an estimated $18 sold.

Vima LLC first reported a position in COCP in Q4 2023 and held it in 3 quarters. The position peaked at $461 in Q1 2024. 4 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

Vima LLC reported no remaining Cocrystal Pharma position as of Q3 2026 after selling out during the quarter.
Vima LLC sold 17 Cocrystal Pharma shares in Q3 2026, an estimated $18.
Vima LLC first reported a position in Cocrystal Pharma in Q4 2023 and held it in 3 quarters.
Vima LLC's Cocrystal Pharma position peaked at $461 in Q1 2024.
4 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Vima LLC's 13F filing for Q3 2026, filed 23 Oct 2026.